RECURSION PHARMACEUT

RXRX
Real-time Estimate Quote. Real-time Estimate  - 05/18 02:39:58 pm
5.515USD -9.74%

SVB Leerink Adjusts Recursion Pharmaceuticals' Price Target to $32 from $30, Keeps Outperform Rating

12/08/2021 | 09:47am
MarketScreener.com
This article is reserved for subscribers
A "one-stop shopping" service for investors
The best opportunities, portfolios, and screeners
Discover